December 13, 2019

Natural Killer Cell Therapeutics Market is Expected to Be the Fastest Growing By 2027


Natural Killer (NK) Cell: Introduction

Natural killer (NK) cells also known as K cells or killer cells. These are a type of white blood cells (lymphocyte) and a component of the innate immune system. Natural killer cells play an important role in the host rejection of virally infected cells and tumors.

View Report –

https://www.transparencymarketresearch.com/natural-killer-nk-cell-therapeutics-market.html

Natural killer cells are cytotoxic. Small granules in natural killer cell cytoplasm contain special proteins, such as proteases and perforin known as granzymes. Once the foreign cell reaches the proximity of the natural killer cell, the natural killer cells attack the foreign cells by releasing protein including perforin that forms stomas in the cell membrane of the target cell through which the associated molecules and granzymes can enter and then induces apoptosis.

Natural killer cells are activated in response to macrophage-derived cytokines and interferons. Patient deficient in natural killer cells is highly prone to early phases of the herpes virus infection.

Request Brochure of Natural Killer Cell Therapeutics Market Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=73692

Key Drivers of Global Natural Killer (NK) Cell Therapeutics Market

The global natural killer (NK) cell therapeutics market is primarily driven by increase in usage of natural killer cells for the treatment of liver and infectious diseases across the globe. According to the Centers for Disease Control and Prevention, in the U.S., in 2016, deaths due to tuberculosis stood at 9,272, salmonella claimed 53,850 lives, Lyme disease caused 36,429 deaths, and 375 people died due to the meningococcal disease. The number of patient visits to physician with parasitic and infectious as the primary diagnosis was reported to be 15.5 million in the U.S. in the same year.

Increase in patient population with infectious and liver diseases is a key driver of the global natural killer (NK) cell therapeutics market

Rise in the awareness among the population about various immunotherapies and increase in research and development of bi-specific antibody for engaging natural killer cells to eliminate tumor cells are driving the global natural killer (NK) cell therapeutics market

Natural Killer (NK) Cell Directed Antibodies Segment Held Major Share of Global Market

Based on type, the global natural killer (NK) cell therapeutics market can be divided into natural killer (NK) cell therapies and natural killer (NK) cell directed antibodies

Natural killer (NK) cell therapies segment can be further divided into CNDO-109, oNKord, natural killer cells, and others

Natural killer (NK) cell directed antibodies segment can sub-divided into MOGAMULIZUMAB, Lirilumab, AFM13, NKTT 120, and others

Natural killer (NK) cell directed antibodies segment accounted for a major market share in 2018. The dominance of the segment can be attributed to increase in the use of monoclonal antibodies (mAbs) for various diseases and easy availability of these drugs.

Request for a Discount on Natural Killer Cell Therapeutics Market Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=73692

Cancer Segment to Offer Attractive Opportunities

In terms of application, the global natural killer (NK) cell therapeutics market can be classified into gastrointestinal diseases, immune-proliferative disorders, cancer, and others.

Cancer segment is expected to account for a major share of the global natural killer (NK) cell therapeutics market in 2027. The dominance of this segment can be attributed to the increase in prevalence rate of cancer across the globe.

North America Natural Killer (NK) Cell Therapeutics Market to Expand Rapidly

Based on region, the global natural killer (NK) cell therapeutics market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to dominate the global market during the forecast period.

Factors such as high prevalence of cancer and new product development are expected to drive the natural killer (NK) cell therapeutics market in North America

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Contact
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: [email protected] Website: http://www.transparencymarketresearch.com